|Market Size||USD 2,585.7 million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||by Raw Material, End Use and Region|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||CapsCanada (Canada), Capsugel (US), Hunan ER-KANG Pharmaceutical Co., Ltd (China), Shanxi Guangsheng Medicinal Capsule Co., Ltd (China), Suheung Co., Ltd (South Korea), ACG (India), and Qualicaps (Mitsubishi Chemical Holdings) (Japan).|
|Key Market Opportunities||Technological Advancements|
|Key Market Drivers||
two-piece empty hard capsule market projected to grow at approximately 7.10% CAGR during the assessment period (2022-2030).
The valuation of the global two-piece empty hard capsule market is estimated to increase to USD 2254.24 Million by the end of 2030.
Rising demand for kosher- and halal-certified capsules, increasing investments in empty hard capsule manufacturing plants, and growing applications in nutraceutical diseases are major tailwinds pushing the growth of the global two-piece empty hard capsule market.
North America holds the largest share in the global two-piece empty hard capsule market, followed by Europe and the Asia Pacific, respectively.
Capsugel, ACG, Hunan ER-KANG Pharmaceutical Co., Ltd, CapsCanada, Shanxi Guangsheng Medicinal Capsule Co., Ltd, QUALICAPS (Mitsubishi Chemical Holdings), and Suheung Co., Ltd., are some of the top players operating in the global two-piece empty hard capsule market.
Global Two-Piece Empty Hard Capsule Market: Competitive Landscape
The global two-piece empty hard capsule market is a huge market with a number of big market players operating in various regions across the world. As there are plenty of large and small market players available, it is very tricky to analyze their market shares in the global market, but through this market study, some major players operating in this market are Capsugel, Qualicaps, ACG, CapsCanada, Suheung Co., Ltd, and others. Apart from these, there are many manufacturers and suppliers involved The global two-piece empty hard capsule market is currently dominated by Capsugel with 25.3% of the total market share. Capsugel has generated exceptional revenue figures and is one of the largest manufacturers of hard capsules worldwide. Moreover, Capsugel the company has 13 manufacturing sites and three research and development centers in nine countries across three continents.
Qualicaps has the second largest market share in the global two-piece empty hard capsules market. Qualicaps hold 24.5% of the total market. Qualicaps has generated massive revenues from the sales of two-piece empty hard capsules. Besides these two, ACG, CapsCanada, Suheung Co., Ltd, have secured third, fourth, and fifth positions with 22.2%, 11.0%, and 8.2% of market share respectively. However, Qualicaps is a leader in innovation in both Quali-G (Gelatin) and Quali-V (Hypromellose) capsules, with more than 100 years of experience, and offers a proprietary product line of pharmaceutical equipment, including capsule filling, band-sealing, and inspection machinery. Qualicaps is focussing on expanding products business and solutions business, focusing on accelerating the global development, and strengthening innovation by incorporation of three chemical operating companies.
Currently, major companies are dropping down the cost of their empty hard capsules across the globe, especially, developing region like Asia, where individuals cannot afford the high cost of the products. On the other hand, the small and medium-size companies are focusing to grab local market with its low cost, which forces the major companies to reduce the price of their products. However, the rising prices of the raw materials and the cultural and religious issues concerned with the consumption of hard capsules containing animal-derived inactive ingredients which may affect the pricing overview for the global market. However, due to increasing prevalence of chronic diseases, governments in developing countries are supporting the empty hard capsules manufacturer for the development of the new and advanced drugs.